Skip to main content

Table 2 Vision improvement in eyes treated with IVTA stratified with respect to change in IOP from baseline

From: Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial

  IOP change < 5 mmHg rise IOP rise 5–9 mmHg IOP rise ≥ 10 mmHg P value
(n = 17) (n = 8) (n = 8)
1 month     
Gain in BCVA ≥ 5 letters 8 (47%) 2 (25%) 7 (88%) 0.044
Mean gain in visual acuity (letters) 4.0 [-0.5 to 6.0] 3.0 [0.0 to 6.3] 6.5 [5.3 to 12.0] 0.058
6 months     
Gain in BCVA ≥ 5 lettersa 9 (56%) 3 (43%) 5 (71%) 0.561
Mean gain in visual acuity (letters)a 4.8 ± 6.5 1.4 ± 7.4 11.7 ± 9.7 0.045
  1. IVTA = intravitreal triamcinolone; IOP = intraocular pressure.
  2. Values are mean ± standard deviation or median with interquartile range shown in box brackets.
  3. an = 16, 7 and 7 for IOP rise <5 mmHg, 5-9 mmHg and ≥10 mmHg, respectively.